References
  1. Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG, et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood. 1999;93(10):3259-66.
  2. Yule SM, Anderson J. Hepatic Cirrhosis and Portal Hypertension in Neuroblastoma. Pediatric Hematol Oncol . 2000;17(6):457-61.
  3. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol . 2009;27(2):298-303.
  4. Kaito S, Doki N, Hishima T, Takaki Y, Ohashi K. Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection.Turk J Haematol . 2019;36(2):130-3.
  5. Dubois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol.1999;21(3):181-9.
  6. Guha C, Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol . 2011;21(4):256-63.
  7. Knapp AB, Crawford JM, Rappeport JM, Gollan JL. Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology.1987;92(2):513-9.
  8. Shimamura M, Murphy-Ullrich JE, Britt WJ. Human cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition. PLoS Pathog . 2010;6(11):e1001170.
  9. Stål P. Iron as a hepatotoxin. Dig Dis. 1995;13(4):205-22.